Lawmakers Demand Answers Over Heparin

Law360, New York (February 21, 2008, 12:00 AM EST) -- A pair of U.S. congressmen is looking for answers from the chief executive of Baxter International, hoping to get to the bottom of the growing controversy surrounding the blood-thinning drug heparin that has recently been tied to four deaths and hundreds of adverse reactions.

On Thursday, Reps. John D. Dingell and Bart Stupak, both Michigan Democrats, sent a letter to Baxter CEO Robert Parkinson asking for further information about a Wall Street Journal report that the U.S. Food and Drug Administration failed to inspect a Chinese...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.